EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C17H17N3O2 |
| Net Charge | 0 |
| Average Mass | 295.342 |
| Monoisotopic Mass | 295.13208 |
| SMILES | CN(C)CC(=O)Nc1ccc2nc(=O)c3ccccc3c2c1 |
| InChI | InChI=1S/C17H17N3O2/c1-20(2)10-16(21)18-11-7-8-15-14(9-11)12-5-3-4-6-13(12)17(22)19-15/h3-9H,10H2,1-2H3,(H,18,21)(H,19,22) |
| InChIKey | UYJZZVDLGDDTCL-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | apoptosis inducer Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms. EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor An EC 2.4.2.* (pentosyltransferase) inhibitor that interferes with the action of a NAD+ ADP-ribosyltransferase (EC 2.4.2.30). |
| Applications: | anti-inflammatory agent Any compound that has anti-inflammatory effects. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. neuroprotective agent Any compound that can be used for the treatment of neurodegenerative disorders. antiatherosclerotic agent A cardiovascular drug that prevents atherosclerosis (a disease in which the inside of an artery narrows due to the build up of plaque). Compare with antiatherogenic agent. cardioprotective agent Any protective agent that is able to prevent damage to the heart. angiogenesis inhibitor An agent and endogenous substances that antagonize or inhibit the development of new blood vessels. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| PJ34 (CHEBI:167900) has role angiogenesis inhibitor (CHEBI:48422) |
| PJ34 (CHEBI:167900) has role anti-inflammatory agent (CHEBI:67079) |
| PJ34 (CHEBI:167900) has role antiatherosclerotic agent (CHEBI:145947) |
| PJ34 (CHEBI:167900) has role antineoplastic agent (CHEBI:35610) |
| PJ34 (CHEBI:167900) has role apoptosis inducer (CHEBI:68495) |
| PJ34 (CHEBI:167900) has role cardioprotective agent (CHEBI:77307) |
| PJ34 (CHEBI:167900) has role EC 2.4.2.30 (NAD+ ADP-ribosyltransferase) inhibitor (CHEBI:62913) |
| PJ34 (CHEBI:167900) has role neuroprotective agent (CHEBI:63726) |
| PJ34 (CHEBI:167900) is a phenanthridines (CHEBI:51245) |
| PJ34 (CHEBI:167900) is a secondary carboxamide (CHEBI:140325) |
| PJ34 (CHEBI:167900) is a tertiary amino compound (CHEBI:50996) |
| PJ34 (CHEBI:167900) is conjugate base of PJ34(1+) (CHEBI:167903) |
| Incoming Relation(s) |
| PJ34(1+) (CHEBI:167903) is conjugate acid of PJ34 (CHEBI:167900) |
| IUPAC Name |
|---|
| 2-(dimethylamino)-N-(6-oxo-5,6-dihydrophenanthridin-2-yl)acetamide |
| Synonyms | Source |
|---|---|
| PJ 34 | ChEBI |
| PJ-34 | ChEBI |
| N2,N2-dimethyl-N-(6-oxo-5,6-dihydrophenanthridin-2-yl)glycinamide | IUPAC |
| 2-(dimethylamino)-N-(6-oxo-5,6-dihydrophenanthridin-2-yl)acetamide | ChEBI |
| 2-(dimethylaminoacetylamino)-5,6-dihydrophenanthridine-6-one | ChEBI |
| N-(5,6-dihydro-6-oxophenanthridine-2-yl)-2-(dimethylamino)acetamide | ChEBI |
| Citations |
|---|